← Back to Analyst Consensus 
VKTX Buy
Viking Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 26
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 2 reiterations from 3 firms
Next Earnings
Oct 28, 2026 (1 day)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 15, 2026 | UBS | initiate | — → Buy | — | 54% |
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Sep 23, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Aug 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 28, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| May 1, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 30, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Mar 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 12, 2025 | Canaccord Genuity | maintain | Buy → Buy | $107 | 48% |
| Oct 29, 2025 | Canaccord Genuity | initiate | — → Buy | $106 | 48% |
| Oct 24, 2025 | JP Morgan | maintain | Overweight → Overweight | $75 | 55% |
| Oct 23, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $102 | 54% |
| Sep 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Sep 22, 2025 | BTIG | reiterate | Buy → Buy | $125 | 52% |
| Aug 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Jul 24, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $122 | 54% |
| Jul 24, 2025 | Citigroup | maintain | Neutral → Neutral | $38 | 54% |
| Jun 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Apr 28, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $104 | 50% |
| Apr 28, 2025 | Truist Securities | reiterate | Buy → Buy | $75 | 55% |
| Apr 24, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $102 | 54% |
| Apr 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Apr 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Apr 8, 2025 | Goldman Sachs | initiate | — → Neutral | $30 | 54% |
| Mar 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Mar 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Feb 13, 2025 | Scotiabank | initiate | — → Sector Outperform | $102 | 55% |
| Feb 7, 2025 | Citigroup | initiate | — → Neutral | $38 | 54% |
| Feb 7, 2025 | Maxim Group | maintain | Buy → Buy | $70 | 42% |
| Feb 7, 2025 | B. Riley Securities | reiterate | Buy → Buy | $96 | 54% |
| Feb 6, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $125 | 54% |
| Feb 6, 2025 | Piper Sandler | maintain | Overweight → Overweight | $71 | 54% |
| Feb 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Jan 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Jan 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $102 | 44% |
| Dec 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Dec 2, 2024 | Piper Sandler | initiate | — → Overweight | $74 | 54% |
| Nov 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Nov 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Nov 22, 2024 | B. Riley Securities | initiate | — → Buy | $109 | 54% |
| Nov 5, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $102 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $90 | 44% |
| Oct 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $90 | 44% |
| Sep 25, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $138 | 52% |
| Sep 12, 2024 | Morgan Stanley | reiterate | Overweight → Overweight | $105 | 54% |
| Sep 11, 2024 | JP Morgan | initiate | — → Overweight | $80 | 55% |
Price Target Trend
Jun 26, 2026 Oct 27, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days